Longitudinal Analysis of the Intestinal Microbiota in Liver Transplantation
暂无分享,去创建一个
S. Ichiyama | S. Uemoto | T. Kaido | Y. Matsumura | M. Nagao | Motomichi Takahashi | K. Oka | K. Miyamoto | Karin Kato | M. Yamamoto
[1] Brian Goodman,et al. The microbiome and cancer , 2018, The Journal of pathology.
[2] P. Hylemon,et al. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis , 2016, Scientific Reports.
[3] S. Ichiyama,et al. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis. , 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[4] D. Brenner,et al. Role of Gut Microbiota in Liver Disease. , 2015, Journal of clinical gastroenterology.
[5] R. Jalan,et al. Clinical and Pathophysiological Consequences of Alterations in the Microbiome in Cirrhosis , 2015, The American Journal of Gastroenterology.
[6] E. Le Chatelier,et al. Qin et al. reply , 2015, Nature.
[7] S. Ichiyama,et al. Changes in Surgical Site Infections after Living Donor Liver Transplantation , 2015, PloS one.
[8] Weilin Wang,et al. Gut microbiota and allogeneic transplantation , 2015, Journal of Translational Medicine.
[9] C. Surawicz,et al. The gut microbiome: a clinically significant player in transplantation? , 2015, Expert review of clinical immunology.
[10] E. Mongodin,et al. Microbiota—implications for immunity and transplantation , 2015, Nature Reviews Nephrology.
[11] Depei Wu,et al. The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease , 2015, Journal of immunology research.
[12] G. Reid,et al. Microbiome Regulation of Autoimmune, Gut and Liver Associated Diseases. , 2015, Inflammation & allergy drug targets.
[13] Nora C. Toussaint,et al. Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation , 2015, PloS one.
[14] S. Uemoto,et al. Perioperative nutritional therapy in liver transplantation , 2015, Surgery Today.
[15] S. Uemoto,et al. Perioperative changes in nutritional parameters and impact of graft size in patients undergoing adult living donor liver transplantation , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[16] Weilin Wang,et al. Intestinal Microbial Variation May Predict Early Acute Rejection after Liver Transplantation in Rats , 2014, Transplantation.
[17] Nora C. Toussaint,et al. Gut Microbial Community Structure and Complications After Kidney Transplantation: A Pilot Study , 2014, Transplantation.
[18] M. Krawczyk,et al. Gut microbiota in cirrhotic liver transplant candidates. , 2014, Hepato-gastroenterology.
[19] Beiwen Zheng,et al. Alterations of the human gut microbiome in liver cirrhosis , 2014, Nature.
[20] W. F. Fricke,et al. Human Microbiota Characterization in the Course of Renal Transplantation , 2014, American Journal of Transplantation.
[21] B. Chassaing,et al. Microbiota‐liver axis in hepatic disease , 2014, Hepatology.
[22] K Ogawa,et al. Impact of Sarcopenia on Survival in Patients Undergoing Living Donor Liver Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] H. Nittono,et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. , 2013, Journal of hepatology.
[24] N. Socci,et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] A. Klindworth,et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies , 2012, Nucleic acids research.
[26] Raul Rabadan,et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. , 2012, Cancer cell.
[27] L. Tang,et al. Comparison of the Gut Microbe Profiles and Numbers Between Patients with Liver Cirrhosis and Healthy Individuals , 2012, Current Microbiology.
[28] Rob Knight,et al. Using QIIME to Analyze 16S rRNA Gene Sequences from Microbial Communities , 2011, Current protocols in bioinformatics.
[29] S. Uemoto,et al. Management of ABO-incompatible living-donor liver transplantation: Past and present trends , 2011, Surgery Today.
[30] G. Cao,et al. Endotoxin accumulation prevents carcinogen‐induced apoptosis and promotes liver tumorigenesis in rodents , 2010, Hepatology.
[31] Y. Maetani,et al. Living donor liver transplantation as a second‐line therapeutic strategy for patients with hepatocellular carcinoma , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[32] R. Ley,et al. Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.
[33] E. Purdom,et al. Diversity of the Human Intestinal Microbial Flora , 2005, Science.
[34] B. Yangco,et al. CDC definitions for nosocomial infections. , 1989, American journal of infection control.
[35] J M Hughes,et al. CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.
[36] K. Watt,et al. The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know. , 2016, Transplantation.